Sekisui XenoTech has announced the appointment of Dr. Darren Warren, PhD, as the company’s new Chief Operating Officer. Dr. Warren has over 15 years of leadership experience with Contract Research ...
Contract Research Organization XenoTech, LLC, a division of Sekisui, has announced plans to relocate into a new 41,500 ft2 facility. The planned move will double the size of XenoTech’s global ...
BioIVT, a leading provider of biospecimens, research models and services for drug and diagnostic development, announced that it has acquired XenoTech, a provider of products for ADME-Tox in vitro ...
XenoTech specializes in providing ADME-Tox products and research services, in particular drug metabolism and pharmacokinetics (DMPK) and drug-drug interaction (DDI) studies WESTBURY, N.Y., Sept. 12, ...
No articles found. Sekisui XenoTech, LLC did not contribute to any primary research papers from Nature Index journals in the current 12 month window. The following affiliated institutions are wholly ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Sekisui XenoTech, a CRO based in Kansas City, Kan., helps ...
BioIVT, a biological specimens and services firm, acquired Sekisui Chemicals CRO division XenoTech for an undisclosed price. (cagkansayin/GettyImages) BioIVT, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results